These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38446130)
1. Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma. Abrishami A; Bahrami AR; Saljooghi AS; Matin MM Nanoscale; 2024 Mar; 16(12):6215-6240. PubMed ID: 38446130 [TBL] [Abstract][Full Text] [Related]
2. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563 [TBL] [Abstract][Full Text] [Related]
3. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells. Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225 [TBL] [Abstract][Full Text] [Related]
4. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423 [TBL] [Abstract][Full Text] [Related]
5. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo. Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028 [TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. Li Y; Duo Y; Bi J; Zeng X; Mei L; Bao S; He L; Shan A; Zhang Y; Yu X Int J Nanomedicine; 2018; 13():1241-1256. PubMed ID: 29535520 [TBL] [Abstract][Full Text] [Related]
7. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857 [TBL] [Abstract][Full Text] [Related]
8. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy. Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488 [TBL] [Abstract][Full Text] [Related]
9. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies. Ansari L; Jaafari MR; Bastami TR; Malaekeh-Nikouei B Artif Cells Nanomed Biotechnol; 2018; 46(sup2):594-606. PubMed ID: 29688064 [TBL] [Abstract][Full Text] [Related]
10. Dual-targeted delivery system using hollow silica nanoparticles with H Mirzaei S; Khademi Z; Zolfaghari R; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM Drug Dev Ind Pharm; 2023 Oct; 49(10):648-657. PubMed ID: 37772892 [TBL] [Abstract][Full Text] [Related]
11. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents. Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677 [TBL] [Abstract][Full Text] [Related]
12. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents. Iranpour S; Bahrami AR; Dayyani M; Saljooghi AS; Matin MM J Mater Chem B; 2024 Jan; 12(4):1096-1114. PubMed ID: 38229578 [TBL] [Abstract][Full Text] [Related]
13. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
14. Smart delivery of epirubicin to cancer cells using aptamer-modified ferritin nanoparticles. Yazdian-Robati R; Bayat P; Dehestani S; Hashemi M; Taghdisi SM; Abnous K J Drug Target; 2022 Jun; 30(5):567-576. PubMed ID: 34991424 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy. Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673 [TBL] [Abstract][Full Text] [Related]
16. Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics. Abrishami A; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM Commun Biol; 2024 Apr; 7(1):393. PubMed ID: 38561432 [TBL] [Abstract][Full Text] [Related]
17. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044 [TBL] [Abstract][Full Text] [Related]
18. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release. Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341 [TBL] [Abstract][Full Text] [Related]